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672a Wednesday, March 4, 2009Potassium and water channels have been the wining channels for 2003 Nobel
prize. The finding of the intrinsic aqueduct orifices and their vital functions
in channel gating shows water flowing merges with ion activity. The orifices
even exist in the newly determined atomic structure of NaK channel (Nature
440, 570-574, 2006), which belongs to another large ion channel family (cyclic
nucleotide-gated channels).
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ChannelTools: A VMD Plugin For Manipulating, Visualizing andMeasur-
ing Ion Channel Properties
Adrian J. Kaats, Jay L. Nadeau, Michael K. Dang’ana.
McGill University, Montreal, QC, Canada.
A new set of software tools has been developed for manipulating, visualiz-
ing, and quantifying properties of ion channels. ChannelTools is a plugin for
the Visual Molecular Dynamics (VMD) program and brings together native
VMD commands and several independent software routines in one simple
graphical user interface. ChannelTools allows quick and easy visualization
of ion channels and employs the HOLE program to visualize the channel
pore and pore lining surface. An option to apply the atomic co-ordinate stan-
dardization previously developed by the authors is implemented yielding
a consistent channel orientation, axis, and geometric centre. By employing
the ESFERA program, pore volume and surface area can be computed
from HOLE program output at the click of a button. Cross-sectional area
and radius profile data and plots can also be generated with a single button
click. Several different routines for estimating channel conductance are also
being developed.
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The advent of high-throughput electrophysiology utilizing Population Patch
Clamp (PPC) technology has allowed the screening of large compound librar-
ies against ion channels representing novel targets in a variety of disease states.
Here we report the design and implementation of an assay enabling the screen-
ing of 56,000 compounds against human TASK-3, a member of the two-P po-
tassium channel family.
cDNA corresponding to the channel of interest was transfected into HEK-293
cells and a stably-expressing clone selected. Ion channel pharmacology was
subsequently validated using Ruthenium Red, Lidocaine, Bupivicaine, Quini-
dine & pH, with all 5 standard inhibitors giving values within two-fold of re-
ported literature values.
The biophysical properties of TASK-3 prevents the use of conventional
methods of leak calculation, however, given the relatively low seal resistance
routinely seen when using IonWorks platforms in a PPC mode, some
form of leak correction must be applied. Currents were recorded at 0mV in or-
der to remove any effect of leak and a final addition of a supramaximal concen-
tration of Ruthenium Red was used in order to calculate a current window from
which to base the efficacy of compounds on.
Assays were performed at pH 7 (EC75) in order to screen for potentiators as
well as inhibitors. Data derived from the voltage step to 0mV was analysed us-
ing Genedata. Inhibitory compounds showing<25% control current and poten-
tiating compounds showing current >150% of control were selected, giving
a hit rate of 5%.
Using the approaches detailed above, this assay has provided a robust screening
platform for large compound collections and could easily be configured for
screening other channels where leak subtraction cannot be applied.
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Ion channels have for several years now, received more and more interest as
drug targets, because of their known involvement in chronic and acute disease.
The frequently cited fact that 15% of the 100 top selling drugs target ion chan-
nels, motivates the pharmaceutical industry to search for techniques that accu-
rately can determine ion channel function, associated with an acceptable data
throughput and reasonable cost per data point. Patch clamp is the gold standard
for obtaining highly relevant information about ion channels and their effectors,but is an extremely laborious technique. This has spurred the development of
automated patch clamps that are capable of high quality recordings, at
a much higher throughput. Up to now, several automated patch clamp platforms
are commercially available which allow for high quality recordings. None of
these meet the throughput requirements given by high throughput screening
in drug discovery.
To meet the ever increasing demand for higher throughput in ion channel
screening and safety testing we have developed a highly parallel patch clamp
platform. The platform supports giga-seal recordings, continuous recording
during compound application and addition of multiple compounds at each of
the 96 cells recorded from at a time. The platform allows recordings in the
whole-cell configuration with high success rates. Due to the open structure of
the patch clamp substrate, dose-responses can be obtained, thus cutting the
costs per data point to be compatible to industrial requirements. Data from dif-
ferent cell types and ion channels will be presented.
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Cardiac arrhythmia is a critical heart condition characterized by abnormal
electrical activity of the heart. There are a wide variety of drugs which are ap-
proved for the treatment of arrhythmia; many of them are acting on voltage
dependent sodium, potassium or calcium channels. One of the problems con-
cerning determination of the major mechanism of action of antiarrhythmics is
that measurement of their effects on the different ion channels is time-consum-
ing and usually done utilizing different experimental conditions. In order to
counter this problem, in this study we applied a novel method, action potential
shape analysis, to determine the effect of selected antiarrhythmics on voltage
dependent sodium, potassium and calcium channels without performing time-
consuming voltage-clamp experiments on each ion channel. Our method is
based on fitting ion channel parameters to intracellularly or extracellularly re-
corded action potentials in a realistic model of NG108-15 cells and quantify-
ing drug effects through their action on the shape of the action potentials and
consequently on the fitted ion channel parameters. For this study we selected
four drugs, quinidine, lidocaine, encanide, and amidarone, representing Class
Ia, Ib, Ic and Class III antiarrhythmics, respectively. Quinidine, encanide and
amidarone blocked both sodium and potassium channels, while lidocaine, at
the measured membrane potential, shifted the activation of sodium channels
in a depolarizing direction. Amidarone showed profound calcium channel
blocking properties. Our work is a first step towards establishing a new assay
system, based on the analysis of the shape of intracellularly and eventually ex-
tracellularly recorded action potentials, which can be used for fast quantitative
analysis of drug effects on ion channel currents and classification of antiar-
rhythmics, and also for measurement of possible cardiac side effects of drug
candidates
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The most studied feature of an ionic channel is the current flowing through it.
This happens when the channel moves into the open state, but most of the
time, as revealed by the low open probability values, the channel transitions
between closed or inactive states. By focusing only when the channel enters
or leaves the open state the most of its activity is being missed. To have a bet-
ter representation of the total behavior of the channel we constructed a com-
puter program (MarkoLAB) that creates a 3-D plot with all channel’s states. In
this graphical interface each state is represented with a column. The height of
the column is proportional to the occupancy level. During voltage clamp sim-
ulation the transition between states are visualized as changes in the columns’
height. This dynamic plot provides more complete information about the
channel behavior and illustrates the stochastic nature of the transitions. Fur-
thermore the macroscopic current is simultaneously shown allowing the user
to link the single channel activity with the overall result of the ensemble cur-
rents. The program was developed in LabVIEW language and the stochastic
transitions were implemented with a Monte Carlo simulation. This first ver-
sion of the software covers three typical channels under voltage clamp condi-
tions: The rapid sodium channel (INa), the slow activated potassium channel
(IKs) and the L-type calcium channel. (ICaL). MarkoLAB is an original tool
to gain insight of the channel kinetics and illustrates more clearly concepts
as recovery from inactivation or distinguish between voltage-dependent versus
calcium-dependent inactivation. This novel representation of channel activity
constitutes a powerful aid to demonstrate effect of gene mutations or drugs on
the channel function.
